May 5th 2025
The 2025 Community Oncology Conference empowered attendees with insights on advocacy, innovation, and practical strategies for enhancing community cancer care.
Adherence to INC Treatment for Nasal Polyposis Remains Low
August 18th 2022Despite intranasal corticosteroid (INCs) being a treatment mainstay for chronic rhinosinusitis with nasal polyps, there are ongoing high rates of nonadherence, which can affect treatment efficacy, according to this study’s authors.
Read More
Drug Survival of Dupilumab Affected by Immunosuppressive Therapy, Older Age in AD
August 18th 2022Investigator Global Assessment score of very severe atopic dermatitis (AD) was associated with dupilumab discontinuation due to adverse effects, although generally adequate 1-, 2-, and 3-year drug survival rates were also observed.
Read More
New Report Highlights Rare Cases of SLE Onset After HPV Vaccination
August 17th 2022A new case report highlights the potential benefits of risk assessment for women with a family history of autoimmune diseases, such as systemic lupus erythematosus (SLE), who are considering the human papillomavirus (HPV) vaccine.
Read More
QCCA Panel Highlights Expansion of Innovation at Independent Community Oncology
August 17th 2022Value management, theranostics, clinical trial access, and a mobile pharmacy are major innovations being integrated into independent community oncology practices, as highlighted at the Quality Cancer Care Alliance Summer 2022 National Leadership Summit.
Read More
Risk of PH Increases With Preterm Birth
August 16th 2022Infants born between the 23rd and 25th weeks of pregnancy, classified as extremely low gestational age newborns, are surviving in increasing numbers, note study authors, and with that is growing clinical interest in their long-term sequelae, including pulmonary hypertension (PH).
Read More
Contributor: Destigmatizing Ketamine for Legitimate Pain Use
August 16th 2022Ketamine has been safely used as an anesthetic in the hospital environment for years, but with the proper training, it can also be administered by a medical professional in a clinical setting to provide pain relief.
Read More
Advocate Speaks on Prior Authorization, Insurance-Related Barriers for HS Treatment
August 13th 2022Brindley Brooks, who founded HS Connect (HSconnect.org), a patient advocacy group for those affected with hidradenitis suppurativa (HS), discussed step edits and other barriers to treatment caused by insurance requirements in the management of HS.
Watch
Whether Hospital Care at Home Continues When Pandemic Emergency Ends Is Up to Congress
August 12th 2022When the pandemic public health emergency eventually ends, so will the various waivers and regulatory flexibilities enacted by HHS during the COVID-19 pandemic, including the ability to provide acute hospital care at home, unless Congress acts.
Read More
Collaborative Care Implementation: Lessons Learned
The authors drafted a “Shared Values of Collaborative Care” document with fundamental principles to make better group decisions in implementing collaborative care.
Read More
Frequent Productive Cough Associated With Worse Outcomes in Asthma, COPD
August 11th 2022Frequent productive cough was experienced by patients with asthma and/or chronic obstructive pulmonary disease (COPD), with symptom prevalence increasing with higher disease severity, according to the results of a recent study.
Read More
Disease Burden of Alopecia Areata Greater in Lower-Income Countries
August 11th 2022Despite decreasing trends observed in the global burden of alopecia areata, low-income countries and Western Sub-Saharan Africa regions continue to exhibit rising incidence and disability-adjusted life-years rates.
Read More
What We're Reading: Drug Pricing Debate; Judge Rules Against Walgreens; Predicting TBI Outcomes
August 11th 2022Policy observers and industry stakeholders debate the possible spillover effects of Medicare drug pricing reform in the employer-based insurance market; a California federal judge rules Walgreens could be held liable for not investigating suspicious orders of opioids in San Francisco; a blood test performed the day of a traumatic brain injury (TBI) can predict which patients may die and who may survive with a disability.
Read More
Race, Insurance Type Among Predictors of Depressive Symptoms in Atopic Dermatitis
August 10th 2022Most patients with atopic dermatitis had flunctuating levels of depressive symptoms, with having public or no insurance, more severe itch, and skin pain cited as additional predictors of adverse mental health outcomes.
Read More
What We’re Reading: Alzheimer Drug Setback; Rural Health Care Investment; Monkeypox Drug Delivery
August 10th 2022Acadia Pharmaceuticals’ pimavanserin (Nuplazid) was not extended by the FDA to include Alzheimer-related psychosis; HHS/Health Resources and Service Administration vow to strengthen rural health care; a new deal has the United States paying $26 million for Siga Technologies’ Tpoxx.
Read More